Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives
Authors:
- Kristoffer KjærgaardKKKristoffer Kjærgaard
- Anne Catrine Daugaard MikkelsenAMAnne Catrine Daugaard Mikkelsen
- Charlotte Wilhelmina WernbergCWCharlotte Wilhelmina Wernberg
- Lea Ladegaard GrønkjærLGLea Ladegaard Grønkjær
- Peter Lykke EriksenPEPeter Lykke Eriksen
- Malene Flensborg DamholdtMalene Flensborg Damholdt
- Rajeshwar Prosad MookerjeeRMRajeshwar Prosad Mookerjee
- Hendrik VilstrupHVHendrik Vilstrup
- Mette Munk LauridsenMLMette Munk Lauridsen
- Karen Louise ThomsenKTKaren Louise Thomsen
Open Access
- 9 February 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (4) , 673
Abstract
Non-alcoholic fatty liver disease (NAFLD) has emerged as the hepatic component of the metabolic syndrome and now seemingly affects one-fourth of the world population. Features associated with NAFLD and the metabolic syndrome have frequently been linked to cognitive dysfunction, i.e. systemic inflammation, vascular dysfunction, and sleep apnoea. However, emerging evidence suggests that NAFLD may be a cause of cognitive dysfunction independent of these factors. NAFLD in addition exhibits dysbiosis of the gut microbiota and impaired urea cycle function, favouring systemic ammonia accumulation and further promotes systemic inflammation. Such disruption of the gut–liver–brain axis is essential in the pathogenesis of hepatic encephalopathy, the neuropsychiatric syndrome associated with progressive liver disease. Considering the growing burden of NAFLD, the morbidity from cognitive impairment is expected to have huge societal and economic impact. The present paper provides a review of the available evidence for cognitive dysfunction in NAFLD and outlines its possible mechanisms. Moreover, the clinical challenges of characterizing and diagnosing cognitive dysfunction in NAFLD are discussed.Keywords
This publication has 162 references indexed in Scilit:
- Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic SteatohepatitisPLOS ONE, 2013
- Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitisWorld Journal of Gastroenterology, 2012
- Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility – Reykjavik StudyBrain, 2011
- Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic InflammationArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Association of MRI Markers of Vascular Brain Injury With Incident Stroke, Mild Cognitive Impairment, Dementia, and MortalityStroke, 2010
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty LiverClinical Gastroenterology and Hepatology, 2009
- Impact of white matter hyperintensity volume progression on rate of cognitive and motor declineNeurology, 2008
- The NAFLD fibrosis scoreHepatology, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005